Potential of [11C]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy

Journal of Nuclear Cardiology

Volumn 17, Issue 2, 2010, Pages 264-275

  Timmer, S A J ^a   Lubberink, M ^a   Germans, T ^a   Gotte M J W ^a   Ten Berg, J M ^b   Ten Cate, F J ^c   Van Rossum, A C ^a   Lammertsma, A A ^a   Knaapen, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

11C acetate; 15O water; Hypertrophic cardiomyopathy; Myocardial blood flow; Positron emission tomography

Indexed keywords

ACETIC ACID; CARBON 11; OXYGEN 15; WATER; ACETIC ACID DERIVATIVE; CARBON; CARBON 11 ACETATE; CARBON-11 ACETATE; OXYGEN;

ADULT; ARTICLE; BLOOD FLOWMETRY; BLOOD VOLUME; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MATHEMATICAL ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; AGED; BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY; HEART MUSCLE; KINETICS; METHODOLOGY; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOLOGY; SCINTISCANNING;

ACETATES; ADULT; AGED; BLOOD FLOW VELOCITY; CARBON; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN CONSUMPTION; OXYGEN ISOTOPES; POSITRON-EMISSION TOMOGRAPHY;

EID: 77953321358     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-009-9181-y     Document Type: Article

References (21)

1. Armbrecht JJ, Buxton DB, Brunken RC, Phelps ME, Schelbert HR. Regional myocardial oxygen consumption determined non-invasively in humans with [1-11C]acetate and dynamic positron tomography. Circulation 1989;80:863-72.
2. Klein LJ, Visser FC, Knaapen P, et al. Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med 2001;28:651-68.
3. Knaapen P, Germans T, Knuuti J, et al. Myocardial energetics and efficiency: Current status of the noninvasive approach. Circulation 2007;115:918-27.
4. Buxton DB, Nienaber CA, Luxen A, et al. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. Circulation 1989;79:134-42.
5. Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 1989;30:187-93.
6. Gropler RJ, Siegel BA, Geltman EM. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med 1991;32:245-51.
7. Herrero P, Kim J, Sharp TL, et al. Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET. J Nucl Med 2006;47:477-85.
8. Sun KT, Yeatman LA, Buxton DB, et al. Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. J Nucl Med 1998;39:272-80.
9. van den Hoff J, Burchert W, Borner AR, et al. [1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med 2001;42:1174-82.
10. Chan SY, Brunken RC, Phelps ME, Schelbert HR. Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. J Nucl Med 1991;32:665-72.
11. Sciacca RR, Akinboboye O, Chou RL, Epstein S, Bergmann SR. Measurement of myocardial blood flow with PET using 1-11C-acetate. J Nucl Med 2001;42:63-70.
12. Porenta G, Cherry S, Czernin J, et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med 1999;26:1465-74.
13. Knaapen P, Germans T, Camici PG, et al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2008; 294:H986-93.
14. Knaapen P, Boellaard R, Gotte MJ, et al. Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. J Nucl Med 2004;45:1299-304.
15. Iida H, Kanno I, Takahashi A, et al. Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 1988;78:104-15.
16. Hermansen F, Rosen SD, Fath-Ordoubadi F, et al. Measurement of myocardial blood flow with oxygen-15 labelled water: Comparison of different administration protocols. Eur J Nucl Med 1998;25:751-9.
17. Buck A, Wolpers HG, Hutchins GD, et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 1991;32:1950-7.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
19. Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 1990;81:1594-605.
20. 13N-ammonia. J Nucl Med 2009;50:1062-71.
21. Cannon RO III, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: Contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985;71:234-43.